IX Biopharma
42C----
Forecast & Rating2 analysts currently cover IX Biopharma, of which 2 give a positive rating. The average price target is S$1.09, about 106.7% upside from the current price of S$0.53. Coverage is limited, so the data is for reference only. Data as of Oct 13, 2026; this does not constitute investment advice.
Oct 12, 2026Price forecast
S$1.08106.67%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateOct 12, 2026
Forecast met0.0%
Stock price$0.53
Avg. target$1.0
High target$1
Low target$1
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.